Clinical Trials Browser

Phase 3 × Completed × temsirolimus × Clear all

NCT01646021 2018-01-19

Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy

Phase 3 Completed

280 enrolled 26 charts

Lymphoma, Mantle-Cell

NCT00631371 2016-04-27

INTORACT

Phase 3 Completed

791 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00117598 2015-03-30

OPTIMAL

Phase 3 Completed

169 enrolled 15 charts

Lymphoma

NCT00474786 2013-11-21

INTORSECT

Phase 3 Completed

512 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00065468 2012-10-25

ARCC

Phase 3 Completed

626 enrolled 18 charts

Carcinoma, Renal Cell, Kidney Neoplasms